Hypoglycemia and risk of vascular events and mortality: a systematic review and meta-analysis (Q38572028)

4 September 2017

0 references

Hypoglycemia and risk of vascular events and mortality: a systematic review and meta-analysis (English)

1 reference

4 September 2017

1 reference

Jong Shiuan Yeh

1

1 reference

4 September 2017

Shih-Hsien Sung

2

1 reference

4 September 2017

Hui-Mei Huang

3

1 reference

4 September 2017

Huei-Ling Yang

4

1 reference

4 September 2017

Li-Kai You

5

1 reference

4 September 2017

Shao-Yuan Chuang

6

1 reference

4 September 2017

Po-Chieh Huang

7

1 reference

4 September 2017

Pai-Feng Hsu

8

1 reference

4 September 2017

Hao-Min Cheng

9

1 reference

4 September 2017

Chen-Huan Chen

10

1 reference

4 September 2017

25 August 2015

1 reference

4 September 2017

1 reference

4 September 2017

53

1 reference

4 September 2017

377-392

1 reference

4 September 2017

3

1 reference

https://scigraph.springernature.com/pub.10.1007/s00592-015-0803-3

4 September 2017

0 references

cites work

Severe hypoglycemia and risks of vascular events and death

1 reference

https://api.crossref.org/works/10.1007%2FS00592-015-0803-3

Hypoglycemia and risk of death in critically ill patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-015-0803-3

Prediction of 90-day mortality in patients without diabetes by severe hypoglycemia: blood glucose level as a novel marker of severity of underlying disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-015-0803-3

10-year follow-up of intensive glucose control in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-015-0803-3

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-015-0803-3

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-015-0803-3

Intensive glycaemic control for patients with type 2 diabetes: systematic review with meta-analysis and trial sequential analysis of randomised clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-015-0803-3

Effects of intensive glucose lowering in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-015-0803-3

Differential clinical outcomes associated with hypoglycemia and hyperglycemia in acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-015-0803-3

Glucometrics in patients hospitalized with acute myocardial infarction: defining the optimal outcomes-based measure of risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-015-0803-3

Serious cardiovascular outcomes in diabetes: the role of hypoglycemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-015-0803-3

Increased mortality of patients with diabetes reporting severe hypoglycemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-015-0803-3

Intensive insulin therapy in the medical ICU.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-015-0803-3

Intensive insulin therapy in critically ill patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-015-0803-3

Hypoglycemia with intensive insulin therapy in critically ill patients: predisposing factors and association with mortality.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-015-0803-3

Haemodynamic changes in insulin-induced hypoglycaemia in normal man

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-015-0803-3

Cardiac arrhythmia and nocturnal hypoglycaemia in type 1 diabetes--the 'dead in bed' syndrome revisited

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-015-0803-3

The proarrhythmic effect of hypoglycemia: evidence for increased risk from ischemia and bradycardia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-015-0803-3

Vascular disease and diabetes: is hypoglycaemia an aggravating factor?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-015-0803-3

Association of hypoglycemia and cardiac ischemia: a study based on continuous monitoring

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-015-0803-3

Association of clinical symptomatic hypoglycemia with cardiovascular events and total mortality in type 2 diabetes: a nationwide population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-015-0803-3

Mild hypoglycemia is strongly associated with increased intensive care unit length of stay

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-015-0803-3

Hypoglycemia-associated mortality is not drug-associated but linked to comorbidities

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-015-0803-3

The association between symptomatic, severe hypoglycaemia and mortality in type 2 diabetes: retrospective epidemiological analysis of the ACCORD study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-015-0803-3

The social burden of hypoglycemia in the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-015-0803-3

Fear of hypoglycemia: relationship to hypoglycemic risk and psychological factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-015-0803-3

Meta-analysis of Observational Studies in Epidemiology: A Proposal for Reporting

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-015-0803-3

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-015-0803-3

Low fasting plasma glucose level as a predictor of cardiovascular disease and all-cause mortality.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-015-0803-3

Is hypoglycaemia a marker for increased long-term mortality risk in patients with coronary artery disease? An 8-year follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-015-0803-3

Association between hyper- and hypoglycaemia and 2 year all-cause mortality risk in diabetic patients with acute coronary events

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-015-0803-3

Intensive insulin therapy and pentastarch resuscitation in severe sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-015-0803-3

The impact of early hypoglycemia and blood glucose variability on outcome in critical illness

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-015-0803-3

A prospective randomised multi-centre controlled trial on tight glucose control by intensive insulin therapy in adult intensive care units: the Glucontrol study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-015-0803-3

Severe hypoglycemia while on intensive insulin therapy is not an independent predictor of death after trauma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-015-0803-3

Hypoglycemia at admission is associated with inhospital mortality in Ugandan patients with severe sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-015-0803-3

Severe hypoglycemia and cardiovascular disease incidence in type 1 diabetes: the EURODIAB Prospective Complications Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-015-0803-3

Hypoglycemia associated with hospitalization and adverse events in older people: population-based cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-015-0803-3

Treatment persistence, hypoglycaemia and clinical outcomes in type 2 diabetes patients with dipeptidyl peptidase-4 inhibitors and sulphonylureas: a primary care database analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-015-0803-3

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-015-0803-3

Repetitive hypoglycaemia increases serum adrenaline and induces monocyte adhesion to the endothelium in rat thoracic aorta.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-015-0803-3

Peripheral blood cell changes in response to acute hypoglycaemia in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-015-0803-3

Platelet aggregation studies during transient hypoglycaemia: a potential method for evaluating platelet function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-015-0803-3

Impact of glycemic and blood pressure variability on surrogate measures of cardiovascular outcomes in type 2 diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-015-0803-3

Impact of glycemic variability on cardiovascular outcomes beyond glycated hemoglobin. Evidence and clinical perspectives.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-015-0803-3

Glucose variability; does it matter?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-015-0803-3

The treat-to-target trial: randomized addition of glargine or human NPH insulin to oral therapy of type 2 diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-015-0803-3

Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-015-0803-3

The continuous glucose monitoring system is useful for detecting unrecognized hypoglycemias in patients with type 1 and type 2 diabetes but is not better than frequent capillary glucose measurements for improving metabolic control

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-015-0803-3

Emergency hospitalizations for adverse drug events in older Americans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-015-0803-3

Risk of hypoglycaemia in types 1 and 2 diabetes: effects of treatment modalities and their duration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-015-0803-3

Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-015-0803-3

The duration of diabetes affects the response to intensive glucose control in type 2 subjects: the VA Diabetes Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-015-0803-3

10.1007/S00592-015-0803-3

21 January 2018

Identifiers

DOI

1 reference

Dimensions Publication ID

4 September 2017

0 references

1 reference